Back
Eventbrite, Inc. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison
Buy
64
EB
Eventbrite, Inc.
Last Price:
$4.45
Seasonality Move:
-14.66%
Sell
41
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$397.66
Seasonality Move:
0.84%
Buy
64
Eventbrite, Inc. (EB)
is a Buy
Is Eventbrite, Inc. a Buy, Sell or Hold?
-
The current Eventbrite, Inc. [EB] share price is $4.44. The Score for EB is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
EB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Sell
Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $397.65. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EB Stock Price Chart
What is Eventbrite, Inc.'s stock price today?
-
The Eventbrite, Inc. share price today is $4.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EB is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals, Inc.'s stock price today?
-
The Alnylam Pharmaceuticals, Inc. share price today is $397.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
EB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 82.44 | Buy |
| Chaikin Money Flow: | -561520 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -12.2 | Sell |
| Relative Strength Index (14 RSI): | 37.79 | Sell |
| Chaikin Money Flow: | -650289 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (391.88 - 446.1) | Sell |
| Bollinger Bands (100): | (422.72 - 470.24) | Sell |
EB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.44 | Buy |
| 20-day SMA: | 4.34 | Buy |
| 50-day SMA: | 3.21 | Buy |
| 200-day SMA: | 2.63 | Buy |
| 8-day EMA: | 4.42 | Buy |
| 20-day EMA: | 4.14 | Buy |
| 50-day EMA: | 3.31 | Buy |
| 200-day EMA: | 1.48 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 400.21 | Sell |
| 20-day SMA: | 411.45 | Sell |
| 50-day SMA: | 436.15 | Sell |
| 200-day SMA: | 371.13 | Buy |
| 8-day EMA: | 399.81 | Sell |
| 20-day EMA: | 410 | Sell |
| 50-day EMA: | 426.22 | Sell |
| 200-day EMA: | 383.9 | Buy |
Eventbrite, Inc. Earnings Growth & EB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.12 per share.
Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.23 per share, and an increase next year of $6.60 per share.
Eventbrite, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||